aspect of
therapy)
→
ReceivesAction
→
assessed by b-mode ultrasonography
| Typicality: | 0.250 |
| Saliency: | 0.000 |
| in hyperlipidemic patients | 6 | other |
| effect → be assessed by → b-mode ultrasonography | 3 |
| negative | neutral | positive |
| 0.209 | 0.751 | 0.040 |
| Raw frequency | 3 |
| Normalized frequency | 0.000 |
| Modifier score | 0.500 |
| Perplexity | 31.579 |